Working… Menu
Trial record 2 of 2 for:    "Bullous Pemphigoid" | "Immunoglobulins, Intravenous"

Phase III Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01408550
Recruitment Status : Completed
First Posted : August 3, 2011
Last Update Posted : October 16, 2013
Information provided by:
Nihon Pharmaceutical Co., Ltd

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 2013
Actual Study Completion Date : September 2013